Novartis Sues Noven To Block Generic Dementia Patch
Novartis AG slapped Hisamitsu Pharmaceutical Co. Inc. and subsidiary Noven Pharmaceuticals Inc. with a lawsuit in Delaware on Wednesday, claiming Noven infringed two patents by seeking U.S. regulatory approval for a...To view the full article, register now.
Already a subscriber? Click here to view full article